Literature DB >> 32913066

Case of prostate stromal tumour of uncertain malignant potential where positron emission tomography with 18F-fluorodeoxyglucose was useful for surgical planning.

Issei Suzuki1, Toshiki Kijima2, Atsuko Owada3, Takao Kamai1.   

Abstract

Stromal tumour of uncertain malignant potential of the prostate is a rare tumour with a variable clinical behaviour ranging from incidentally detected indolent tumours that never progress, to aggressive diseases almost identical to sarcomas that may invade surrounding organs or develop metastases. Surgical excision is generally recommended for local diseases; however, owing to its diverse clinical outcomes, optimal management may vary from surgery alone to wide excision combined with chemotherapy and/or radiotherapy. Therefore, preoperative evaluation of the malignant potential of the disease is essential to decide the treatment strategy. Herein, we report a case of stromal tumour of uncertain malignant potential successfully treated with minimally invasive robot-assisted radical prostatectomy alone under the diagnosis of the disease with low malignant potential based on the findings of positron emission tomography with 18F-fluorodeoxyglucose. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  pathology; prostate cancer; urological surgery

Mesh:

Substances:

Year:  2020        PMID: 32913066      PMCID: PMC7484856          DOI: 10.1136/bcr-2020-235738

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  24 in total

1.  The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level.

Authors:  Ryogo Minamimoto; Hiroji Uemura; Futoshi Sano; Hideyuki Terao; Yoji Nagashima; Shoji Yamanaka; Kazuya Shizukuishi; Ukihide Tateishi; Yoshinobu Kubota; Tomio Inoue
Journal:  Ann Nucl Med       Date:  2010-10-08       Impact factor: 2.668

2.  18F-FDG PET/CT Imaging in an Adolescent Patient With Primary Prostatic Stromal Sarcoma.

Authors:  Ruihe Lai; Chongyang Ding
Journal:  Clin Nucl Med       Date:  2019-01       Impact factor: 7.794

Review 3.  PET Imaging in Sarcoma.

Authors:  Stephen Becher; Shervin Oskouei
Journal:  Orthop Clin North Am       Date:  2015-04-11       Impact factor: 2.472

4.  Association of overall survival with glycolytic activity of castrate-resistant prostate cancer metastases.

Authors:  Hossein Jadvar; Susan G Groshen; David I Quinn
Journal:  Radiology       Date:  2015-02       Impact factor: 11.105

Review 5.  Stromal tumor of uncertain malignant potential of the prostate.

Authors:  Lauren M Murer; Geoffrey A Talmon
Journal:  Arch Pathol Lab Med       Date:  2014-11       Impact factor: 5.534

Review 6.  Sarcomas and related proliferative lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases.

Authors:  P B Gaudin; J Rosai; J I Epstein
Journal:  Am J Surg Pathol       Date:  1998-02       Impact factor: 6.394

7.  Prostatic Stromal Tumors of Uncertain Malignant Potential.

Authors:  Joon Yau Leong; Thenappan Chandrasekar; Christopher Sebastiano; Hamza Rshaidat; James E Steward; Edouard J Trabulsi
Journal:  Urology       Date:  2019-06-26       Impact factor: 2.649

8.  FDG PET/CT Imaging of Prostate Carcinosarcoma.

Authors:  Jorge Daniel Oldan; Bennett B Chin
Journal:  Clin Nucl Med       Date:  2016-08       Impact factor: 7.794

9.  Maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography/computed tomography improves outcome prediction in retroperitoneal liposarcoma.

Authors:  Jinsoo Rhu; Seung Hyup Hyun; Kyung-Han Lee; Sung Jun Jo; Kyo Won Lee; Jae Berm Park; Sung Joo Kim
Journal:  Sci Rep       Date:  2019-04-29       Impact factor: 4.379

10.  Differentiation of aggressive and indolent subtypes of uterine sarcoma using maximum standardized uptake value.

Authors:  Elaine Yuen Phin Lee; Pek-Lan Khong; Ka Yu Tse; Karen Kar Loen Chan; Mandy Man Yee Chu; Hextan Yuen Sheung Ngan
Journal:  Nucl Med Commun       Date:  2013-12       Impact factor: 1.690

View more
  1 in total

1.  A case of incidental STUMP discovery in a patient with concurrent prostatic adenocarcinoma.

Authors:  Tessa Ladner; Troy Schultz; Jocelyn Moore; Greg Houle
Journal:  J Surg Case Rep       Date:  2021-12-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.